Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
  1. Home
  2. Products
  3. 5000247695

Medchemexpress LLC Tasurgratinib succinate | 1879965-80-6 | 99.2% | 705.8 g/mol | C32H37N5O6.3/2C4H6O4 | 10 MG
SDP

Catalog No. 5000247695
Encompass_Preferred

Tasurgratinib succinate (E7090) is an orally available, selective inhibitor of fibroblast growth factor receptors FGFR1-3 used in preclinical oncology research. It potently inhibits FGFR signaling at low-nanomolar concentrations and has demonstrated antiproliferative activity in FGFR-driven cancer cell lines.

  • Selective FGFR1-3 inhibition with low-nanomolar potency.
  • Demonstrated antiproliferative activity in FGFR-driven cell lines.
  • Supplied as the succinate salt for preclinical experiments.
  • High purity suitable for biochemical and cellular assays.
  • Provided in small-mass packages for research use.

Catalog No. 50-002-47695 Supplier Medchemexpress LLC Supplier No. HY101466A10MG
May include imposed supplier surcharges.
Add to Cart
Add to Cart

missing translation for 'validMainframeMsg'

Tasurgratinib succinate (E7090) is an orally available, selective inhibitor of fibroblast growth factor receptors FGFR1-3 used in preclinical oncology research. It potently inhibits FGFR signaling at low-nanomolar concentrations and has demonstrated antiproliferative activity in FGFR-driven cancer cell lines.

  • Selective FGFR1-3 inhibition with low-nanomolar potency.
  • Demonstrated antiproliferative activity in FGFR-driven cell lines.
  • Supplied as the succinate salt for preclinical experiments.
  • High purity suitable for biochemical and cellular assays.
  • Provided in small-mass packages for research use.

Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.